NMR Experiment |
---|
Experiment | Type | Sample Contents | Solvent | Ionic Strength | pH | Pressure | Temperature (K) | Spectrometer |
---|
1 | 2D 1H-15N HSQC | 1 mM [U-100% 13C; U-100% 15N] ATC0905, 10 mM [U-100% 2H] TRIS, 300 mM sodium chloride, 10 mM DTT, 1 uM benzamidine, 1 x Roche inhibitor cocktail | 90% H2O/10% D2O | | 7.0 | ambient | 298 | |
2 | 2D 1H-13C HSQC | 1 mM [U-100% 13C; U-100% 15N] ATC0905, 10 mM [U-100% 2H] TRIS, 300 mM sodium chloride, 10 mM DTT, 1 uM benzamidine, 1 x Roche inhibitor cocktail | 90% H2O/10% D2O | | 7.0 | ambient | 298 | |
3 | 3D HNCO | 1 mM [U-100% 13C; U-100% 15N] ATC0905, 10 mM [U-100% 2H] TRIS, 300 mM sodium chloride, 10 mM DTT, 1 uM benzamidine, 1 x Roche inhibitor cocktail | 90% H2O/10% D2O | | 7.0 | ambient | 298 | |
4 | 3D CBCA(CO)NH | 1 mM [U-100% 13C; U-100% 15N] ATC0905, 10 mM [U-100% 2H] TRIS, 300 mM sodium chloride, 10 mM DTT, 1 uM benzamidine, 1 x Roche inhibitor cocktail | 90% H2O/10% D2O | | 7.0 | ambient | 298 | |
5 | 3D HNCA | 1 mM [U-100% 13C; U-100% 15N] ATC0905, 10 mM [U-100% 2H] TRIS, 300 mM sodium chloride, 10 mM DTT, 1 uM benzamidine, 1 x Roche inhibitor cocktail | 90% H2O/10% D2O | | 7.0 | ambient | 298 | |
6 | 3D 1H-13C arom NOESY | 1 mM [U-100% 13C; U-100% 15N] ATC0905, 10 mM [U-100% 2H] TRIS, 300 mM sodium chloride, 10 mM DTT, 1 uM benzamidine, 1 x Roche inhibitor cocktail | 90% H2O/10% D2O | | 7.0 | ambient | 298 | |
7 | 3D 1H-15N NOESY | 1 mM [U-100% 13C; U-100% 15N] ATC0905, 10 mM [U-100% 2H] TRIS, 300 mM sodium chloride, 10 mM DTT, 1 uM benzamidine, 1 x Roche inhibitor cocktail | 90% H2O/10% D2O | | 7.0 | ambient | 298 | |
8 | 3D 1H-13C NOESY | 1 mM [U-100% 13C; U-100% 15N] ATC0905, 10 mM [U-100% 2H] TRIS, 300 mM sodium chloride, 10 mM DTT, 1 uM benzamidine, 1 x Roche inhibitor cocktail | 90% H2O/10% D2O | | 7.0 | ambient | 298 | |
9 | 3D HBHA(CO)NH | 1 mM [U-100% 13C; U-100% 15N] ATC0905, 10 mM [U-100% 2H] TRIS, 300 mM sodium chloride, 10 mM DTT, 1 uM benzamidine, 1 x Roche inhibitor cocktail | 90% H2O/10% D2O | | 7.0 | ambient | 298 | |
10 | 3D H(C)CH-TOCSY aliphatic | 1 mM [U-100% 13C; U-100% 15N] ATC0905, 10 mM [U-100% 2H] TRIS, 300 mM sodium chloride, 10 mM DTT, 1 uM benzamidine, 1 x Roche inhibitor cocktail | 90% H2O/10% D2O | | 7.0 | ambient | 298 | |
11 | 3D CCH-TOCSY aliphatic | 1 mM [U-100% 13C; U-100% 15N] ATC0905, 10 mM [U-100% 2H] TRIS, 300 mM sodium chloride, 10 mM DTT, 1 uM benzamidine, 1 x Roche inhibitor cocktail | 90% H2O/10% D2O | | 7.0 | ambient | 298 | |
12 | 2D 1H-13C HSQC CT | 1 mM [U-100% 13C; U-100% 15N] ATC0905, 10 mM [U-100% 2H] TRIS, 300 mM sodium chloride, 10 mM DTT, 1 uM benzamidine, 1 x Roche inhibitor cocktail | 90% H2O/10% D2O | | 7.0 | ambient | 298 | |
13 | 2D 1H-13C HSQC arom | 1 mM [U-100% 13C; U-100% 15N] ATC0905, 10 mM [U-100% 2H] TRIS, 300 mM sodium chloride, 10 mM DTT, 1 uM benzamidine, 1 x Roche inhibitor cocktail | 90% H2O/10% D2O | | 7.0 | ambient | 298 | |
14 | 2D HBCBCGCDHD | 1 mM [U-100% 13C; U-100% 15N] ATC0905, 10 mM [U-100% 2H] TRIS, 300 mM sodium chloride, 10 mM DTT, 1 uM benzamidine, 1 x Roche inhibitor cocktail | 90% H2O/10% D2O | | 7.0 | ambient | 298 | |